Year-end Sale % OFF 
Abstract
Chemotherapy-related cardiotoxicity is common and has become one of the factors that affect the prognosis of patients. Early identification and intervention of chemotherapy-related cardiotoxicity is very important. Currently, the commonly used clinical, imaging and laboratory examination methods have their own shortcomings, while PET/CT imaging has not been widely used for chemotherapy-related cardiotoxicity. This article reviews the current application and deficiencies of PET/CT imaging in animal experiments and human trials of chemotherapy-related cardiotoxicity. Key words: Cardiotoxicity; Drug therapy; Positron-emission tomography; Tomography, X-ray computed; Trends
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Chinese Journal of Nuclear Medicine and Molecular Imaging
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
